Recursion Pharmaceuticals - Class A (RXRX)'s 30-day implied volatility (IV30) was 67.0% at the close on November 10, 2026, down from 78.5% the day before, against a 52-week range of 42.5% to 105.6%. Its 20-day historical volatility was 97.7%.
Data as of November 10, 2026.